EBILITY TABLET is a combination of Diclofenac, Paracetamol and Serratiopeptidase which belongs to the group of medicines called Nonsteroidal Anti-inflammatory Drugs (NSAID),  Analgesics and Anti-pyrectics. It is used to relieve symptoms such as fever, pain and inflammation associated with musculoskeletal and joint disorders.

EBILITY TABLET is not recommended for use in patients with asthma (aspirin sensitive asthma), urticaria or acute rhinitis precipitated by aspirin or other NSAIDs, severe liver disease or kidney disease, severe congestive heart failure, ischemic heart disease (heart attack), blockages of blood vessels to the heart and in patients with history or active peptic ulcer, bleeding (blood in stools, vomiting blood) or perforation or active gastrointestinal bleeding.

EBILITY TABLET should be used with caution in patients with pre-existing asthma, seasonal allergic rhinitis, nasal polyps, chronic obstructive pulmonary disease or chronic infections of the respiratory tract, mild to moderate congestive heart failure and high blood pressure.

EBILITY TABLET is not recommended for use in children. It should be used with caution in elderly patients (aged 65 years or above). Consult your doctor before taking EBILITY TABLET.

The most common side effects of taking EBILITY TABLET are nausea, vomiting, stomach pain, diarrhoea, indigestion, flatulence and gastritis. Consult your physician if any of the side effects worsen during or after management with EBILITY TABLET.